Armodafinil and Modafinil Have Substantially Different Pharmacokinetic Profiles Despite Having the Same Terminal Half-Lives: Analysis of Data from Three Randomized, Single-Dose, Pharmacokinetic Studies

By Darwish Mona  

Clinical Drug Investigation, Vol. 29, Iss. 9, 2009-09 ,pp. : 613-623

Adis International

Access to resources Recommend Favorite

Comparison of Steady-State Plasma Concentrations of Armodafinil and Modafinil Late in the Day Following Morning Administration: Post Hoc Analysis of Two Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Studies in Healthy Male Subjects

By Darwish Mona  

Clinical Drug Investigation, Vol. 29, Iss. 9, 2009-09 ,pp. : 601-612

Adis International

Access to resources Recommend Favorite

Once-Daily Trospium Chloride 60 mg Extended Release in Subjects with Overactive Bladder Syndrome Who Use Multiple Concomitant Medications: Post hoc Analysis of Pooled Data from Two Randomized, Placebo-Controlled Trials

By Sand Peter K.  

Drugs & Aging, Vol. 28, Iss. 2, 2011-02 ,pp. : 151-160

Adis International

Access to resources Recommend Favorite

Safety profile of standard- vs. high-dose peginterferon alfa-2a plus standard-dose ribavirin in HCV genotype 1/4 patients: pooled analysis from 5 randomized studies

By Marcellin Patrick   Roberts Stuart K   Reddy K Rajender   Harrison Stephen A   Jensen Donald M   Hadziyannis Stephanos   Diago Moises   Weltman Martin   Messinger Diethelm   Tatsch Fernando   Rizzetto Mario  

Expert Opinion on Drug Safety, Vol. 11, Iss. 6, 2012-11 ,pp. : 901-909

Informa Healthcare

Access to resources Recommend Favorite

Interaction Profile of Armodafinil with Medications Metabolized by Cytochrome P450 Enzymes 1A2, 3A4 and 2C19 in Healthy Subjects

By Darwish Mona  

Clinical Pharmacokinetics, Vol. 47, Iss. 1, 2008-01 ,pp. : 61-74

Adis International

Access to resources Recommend Favorite